Font Size Units

Home / News

Ovid Embase – Trial ended Jun 30 2020
[Trials] 2020-06-01

Trial expires: 
June 30, 2020


To successfully perform critical functions such as pharmacovigilance, generating high-quality systematic reviews in support of evidence-based medicine and drug and medical device efficacy studies, pharmaceutical and life sciences organizations require a wide array of biomedical evidence.
Embase increases the discovery of biomedical evidence to support critical life sciences functions, delivering relevant, up-to-date biomedical information to the global biomedical research community.

Key features:

  • Over 30 million abstracts and indices from more than 8,500 published, peer-reviewed journals, as well as in-press publications and conferences
  • More than 6 million records and indexes 2,900 journals NOT covered in MEDLINE
  • Full-text indexing of drug, disease and medical device data, supported by the precise Emtree thesaurus

How to Access the resource:
1. Login the E-resources system
2. Search "Embase", and select "Ovid Embase"

Contact Information
Taipei Medical University Library
Address:250 Wuxing St. Taipei 11031
TEL:886-2-27361661 #2514-2515
Last Updated:2020-07-10

©Taipei Medical University Library    Privacy Policy    Copyright    Security Policy   Resolution: 1024 * 768 or more